BIO-B Stock 12 Month Analyst Forecast
Eps Overview
Consensus Rating
Consensus Price Target
Highest Price Target
N/A
0% Upside
Mean Price Target
N/A
0% Upside
Lowest Price Target
N/A
0% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Last Updated On N/A
Actual EPS vs Estimated EPS
BIO-B Earnings Per Share (EPS) History
According to financial reports, BIO-B (NYSE: BIO-B) reported an actual EPS of $2.26 for the quarter ending on Oct 29, 2025, compared to an estimated $1.89, resulting in a 19.58% surprise. In the prior quarter (Oct 28, 2025), BIO-B recorded an actual EPS of $-12.69918 with a -771.91% surprise. See BIO-B's full earnings history.
Earnings History
EPS Surprise Factor Analysis
BIO-B has experienced notable EPS surprises, with the latest quarter ending Oct 29, 2025 showing a 19.58% beat. Previously, the quarter ending Oct 28, 2025 recorded a -771.91% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Oct 29, 2025 | 2.26 | 1.89 | +19.58% |
| Oct 28, 2025 | -12.69918 | 1.89 | -771.91% |
| Aug 04, 2025 | 11.67 | 1.75 | +566.86% |
| Jul 31, 2025 | 11.67 | 1.75 | +566.86% |
| Jul 30, 2025 | 11.67 | 1.75 | +566.86% |
| May 05, 2025 | 2.29 | 1.82 | +25.82% |
After EPS Prices
BIO-B stock frequently reacts to earnings reports. Following the Oct 29, 2025 earnings, the share price saw a N/A% rise before closing. On the 7th day after the report, BIO-B shares recorded a N/A% gain. Analyze historical BIO-B stock performance post-earnings.
| Earning Date | Before EPS Change | Next Day Closing Price | 7th Day Closing Price |
|---|---|---|---|
| Oct 29, 2025 | -- | $303.15- | $305.40- |
| Oct 28, 2025 | -- | -- | $305.40- |
| Aug 04, 2025 | -- | $247.050 | -- |
| Jul 31, 2025 | $247.050 | -- | $247.050 |
| Jul 30, 2025 | $247.050 | $247.050 | $247.050 |
| May 05, 2025 | -- | -- | -- |

